首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Vitamin A supplementation in iodine-deficient African children decreases thyrotropin stimulation of the thyroid and reduces the goiter rate
【24h】

Vitamin A supplementation in iodine-deficient African children decreases thyrotropin stimulation of the thyroid and reduces the goiter rate

机译:在非洲缺碘儿童中补充维生素A可减少甲状腺促甲状腺激素的刺激并降低甲状腺肿大率

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Vitamin A (VA) deficiency (VAD) and iodine deficiency (ID) often coexist in children in Africa. VAD may affect thyroid function and the response to iodine prophylaxis. OBJECTIVE: The aim was to investigate the effects of supplementation with iodine or VA alone, and in combination, in children with concurrent VAD and ID. DESIGN: A 6-mo randomized, double-blind, 2 x 2 intervention trial was conducted in 5-14 y-old South African children (n = 404), who, on average, had mild-to-moderate VAD and ID. At baseline and after 3 mo, children received 1) iodine (191 mg I as oral iodized oil) + placebo (IS group), 2) VA (200000 IU VA as retinyl palmitate) + placebo (VAS group), 3) both iodine and VA (IS+VAS group), or 4) placebo. At baseline, 3 mo, and 6 mo, urinary iodine (UI), thyroid volume, thyrotropin (thyroid-stimulating hormone; TSH), total thyroxine (TT(4)), thyroglobulin, serum retinol (SR), and retinol-binding protein (RBP) were measured. RESULTS: SR and RBP increased significantly with VA supplementation (P < 0.05). For UI, SR, and RBP, there were no significant treatment interactions between iodine and vitamin A. The 3-factor and all three 2-factor interactions were significant for thyroid volume, TSH, and thyroglobulin (P < 0.001), whereas none of these interactions were significant for TT(4). There was a clear effect of VAS without IS on TSH, thyroglobulin, and thyroid volume; all 3 variables decreased significantly (P < 0.05). CONCLUSIONS: Iodine prophylaxis is effective in controlling ID in areas of poor vitamin A status. VA supplements are effective in treating VAD in areas of mild ID and have an additional benefit-through suppression of the pituitary TSHbeta gene, VAS can decrease excess TSH stimulation of the thyroid and thereby reduce the risk of goiter and its sequelae.
机译:背景:维生素A(VA)缺乏症(VAD)和碘缺乏症(ID)通常在非洲儿童中共存。 VAD可能会影响甲状腺功能以及对碘预防的反应。目的:研究单独补充碘或VA,以及联合使用对补充VAD和ID的儿童的影响。设计:对5-14岁的南非儿童(n = 404)进行了为期6个月的随机,双盲,2 x 2干预试验,他们平均具有轻度至中度的VAD和ID。在基线和3个月后,儿童接受1)碘(口服碘化油191 mg I)+安慰剂(IS组),2)VA(200000 IU VA棕榈酸视黄酯)+安慰剂(VAS组),3)碘和VA(IS + VAS组),或4)安慰剂。基线时分别为3 mo和6 mo,尿碘(UI),甲状腺容量,促甲状腺激素(促甲状腺激素; TSH),总甲状腺素(TT(4)),甲状腺球蛋白,血清视黄醇(SR)和视黄醇结合测定蛋白质(RBP)。结果:随着VA的补充,SR和RBP显着增加(P <0.05)。对于UI,SR和RBP,碘和维生素A之间没有显着的治疗相互作用。3因子和所有3个2因子相互作用对甲状腺容量,TSH和甲状腺球蛋白均具有显着意义(P <0.001),而这些相互作用对TT(4)具有重要意义。没有IS的VAS对TSH,甲状腺球蛋白和甲状腺容量有明显作用;所有三个变量均显着下降(P <0.05)。结论:在维生素A状况不佳的地区,碘预防可有效控制ID。 VA补充剂可有效治疗轻度ID区域的VAD,并具有通过抑制垂体TSHbeta基因的额外益处,VAS可减少甲状腺对TSH的过度刺激,从而降低甲状腺肿及其后遗症的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号